Palladium (II) Acetate

Company Information

Ask for more detail from the seller

Report incorrect details

Application :

An ingredient of catalyst to produce vinyl acetate;
Precursor to produce other palladium compounds including metal organic compounds and materials containing palladium
Catalyst of polyketones synthesis. Grantor of license: Shell (Carilon®) BP (Ketonex®)
Catalyst of methyl methacrylate synthesis. Grantor of license: Lucite (Alpha process)
Reagent for Montelukast antiasthma agent synthesis (Merck company)
Reagent for Resveratrol antineoplastic agent synthesis (DSM company)
Reagent for Rilpivirine synthesis, a medicine for HIV and AIDS treatment (Janssen Pharmaceuticals company)
Reagent for Eletriptan antimigraine agent synthesis (Pfizer company)
Reagent for Pemetrexed disodium antineoplastic agent synthesis (Eli Lilly company)
Reagent for Varenicline synthesis, a medicine assisting to quit smoking (Pfizer company).

Indicators	Trial Data Results
Indicators	Type 1	Type 2
Form	Red-orange-coloured crystalline powder
Mass fraction of palladium, %	46.5—48	47.5—48.5
Solubility in acetone, %, min.	98	98
Mass fraction of admixtures, %, max.:
platinum, rhodium, iridium, ruthenium, gold, silver (each)	0	—
platinum, rhodium, iridium, ruthenium (sum)	—	0.01
aluminium	—	0.01
iron	0	0.01
calcium	0	0.01
silicon	0	0.01
magnesium	0	0.01
manganese	—	0
copper	0	0
lead	0	0
chromium	—	0
zinc	—	0